Literature DB >> 11883149

In vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leaves.

B Singh1, A K Saxena, B K Chandan, S G Agarwal, K K Anand.   

Abstract

The alcoholic extract of fresh leaves of the plant Eclipta alba (Ea), previously reported for is hepatoprotective activity was fractionated into three parts to chemically identify the most potent bioactive fraction. The hepatoprotective potential of the fraction prepared from extract was studied in vivo in rats and mice against carbon tetrachloride induced hepatotoxicity. The hepatoprotective activity was determined on the basis of their effects on parameters like hexobarbitone sleep time, zoxazolamine paralysis time, bromosulphaline clearance, serum transaminases and serum bilirubin. Fraction EaII (10-80 mg/kg, p.o.) containing coumestan wedelolactone and desmethylwedelolactone as major components with apigenin, luteolin, 4-hydroxybenzoic acid and protocateuic acid as minor constituents exhibited maximum hepatoprotective activity and is the active fraction for hepatoprotective activity of Eclipta alba leave. The acute toxicity studies have shown that like Ea, Fraction EaII also high safety margin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11883149

Source DB:  PubMed          Journal:  Indian J Physiol Pharmacol        ISSN: 0019-5499


  17 in total

1.  Hepatoprotective and antioxidant effects of Argyreia speciosa in rats.

Authors:  P V Habbu; R A Shastry; K M Mahadevan; Hanumanthachar Joshi; S K Das
Journal:  Afr J Tradit Complement Altern Med       Date:  2008-01-22

2.  The in vitro anti-giardial activity of extracts from plants that are used for self-medication by AIDS patients in southern Thailand.

Authors:  N Sawangjaroen; S Subhadhirasakul; S Phongpaichit; C Siripanth; K Jamjaroen; K Sawangjaroen
Journal:  Parasitol Res       Date:  2004-11-18       Impact factor: 2.289

3.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

4.  Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells.

Authors:  Sivalokanathan Sarveswaran; Ritisha Ghosh; Rujul Parikh; Jagadananda Ghosh
Journal:  Mol Cancer Ther       Date:  2016-07-29       Impact factor: 6.261

5.  Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta alba.

Authors:  Dinesh Manvar; Mahesh Mishra; Suriender Kumar; Virendra N Pandey
Journal:  J Ethnopharmacol       Date:  2012-09-28       Impact factor: 4.360

6.  Propolis protects CYP 2E1 enzymatic activity and oxidative stress induced by carbon tetrachloride.

Authors:  Monika Bhadauria; Satendra Kumar Nirala; Sangeeta Shukla
Journal:  Mol Cell Biochem       Date:  2007-04-05       Impact factor: 3.396

7.  Pharmacological Mechanisms Underlying the Hepatoprotective Effects of Ecliptae herba on Hepatocellular Carcinoma.

Authors:  Botao Pan; Wenxiu Pan; Zheng Lu; Chenglai Xia
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-16       Impact factor: 2.629

8.  Evaluation of protective effect of Sapindus mukorossi saponin fraction on CCl(4)-induced acute hepatotoxicity in rats.

Authors:  M Srinivasa Rao; B Syed Asad; Ma Fazil; Rd Sudharshan; Sa Rasheed; Ha Pradeep; S Aboobacker; Ah Thayyil; Ak Riyaz; M Mansoor; Ma Aleem; K Zeeyauddin; M Lakshmi Narasu; A Anjum; M Ibrahim
Journal:  Clin Exp Gastroenterol       Date:  2012-07-17

9.  Clinical efficacy of Bhringarajasava as Naimittika Rasayana in Rajayakshma with special reference to pulmonary tuberculosis.

Authors:  Sathya N Dornala; Snehalatha S N Dornala
Journal:  Ayu       Date:  2012-10

10.  Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt.

Authors:  Sivalokanathan Sarveswaran; Subhash C Gautam; Jagadananda Ghosh
Journal:  Int J Oncol       Date:  2012-10-16       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.